Human alpha-thrombin inhibition by the highly selective compounds N-ethoxycarbonyl-D-Phe-Pro-alpha-azaLys p-nitrophenyl ester and N-carbobenzoxy-Pro-alpha-azaLys p-nitrophenyl ester: A kinetic, thermodynamic and x-ray crystallographic study

被引:14
作者
DeSimone, G
Balliano, G
Milla, P
Gallina, C
Giordano, C
Tarricone, C
Rizzi, M
Bolognesi, M
Ascenzi, P
机构
[1] UNIV PAVIA, DEPT GENET & MICROBIOL, I-27100 PAVIA, ITALY
[2] UNIV NAPLES, DEPT CHEM, I-80134 NAPLES, ITALY
[3] UNIV TURIN, DEPT PHARMACEUT CHEM & TECHNOL, I-10125 TURIN, ITALY
[4] UNIV CHIETI, INST PHARMACEUT SCI, I-66100 CHIETI, ITALY
[5] UNIV ROMA LA SAPIENZA, CNR, CTR MED CHEM, I-00185 ROME, ITALY
[6] UNIV ROMA LA SAPIENZA, DEPT PHARMACEUT STUDIES, I-00185 ROME, ITALY
[7] UNIV GENOA, ADV BIOTECHNOL CTR, I-16132 GENOA, ITALY
[8] UNIV GENOA, DEPT PHYS, I-16132 GENOA, ITALY
[9] UNIV ROME 3, DEPT BIOL, I-00146 ROME, ITALY
关键词
human chi-thrombin; N-ethoxycarbonyl-D-Phe-Pro-chi-azaLys p-nitrophenyl ester; N-carbobenzoxy-Pro-chi-azaLys p-nitrophenyl ester; serine proteinase inhibition; X-ray crystal structure;
D O I
10.1006/jmbi.1997.1037
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Kinetics, thermodynamics and structural aspects of human alpha-thrombin (thrombin) inhibition by newly synthesized low molecular weight derivatives of alpha-azalysine have been investigated. The thrombin catalyzed hydrolysis of N-ethoxycarbonyl-D-Phe-Pro-alpha-azaLys p-nitrophenyl ester (Eoc-D-Phe-Pro-azaLys-ONp) and N-carbobenzoxy-Pro-alpha-azaLys p-nitrophenyl ester (Cbz-Pro-azaLys-ONp) was investigated at pH 6.2 and 21.0 degrees C, and analyzed in parallel with that of N-alpha-(N,N-dimethylcarbamoyl)-alpha-azalysine p-nitrophenyl ester (Dmc-azaLys-ONp). Decarboxylation following the enzymatic hydrolysis of these p-nitrophenyl esters gave the corresponding 1-peptidyl-2(4-aminobutyl) hydrazines (peptidyl-Abh) showing properties of thrombin competitive inhibitors. Therefore, thermodynamics for the reversible binding of D-Phe-Pro-Abh, Cbz-Pro-Abh and Dmc-Abh to thrombin was examined. These results are consistent with the minimum four-step catalytic mechanism for product inhibition of serine proteinases. Eoc-D-Phe-Pro-azaLys-ONp and Eoc-D-Phe-Pro-Abh display a sub-micromolar affinity for thrombin together with a high selectivity versus homologous plasmatic and pancreatic serine proteinases acting on cationic substrates. The three-dimensional structures of the reversible non-covalent thrombin:Eoc-D-Phe-Pro-Abh and thrombin:Cbz-Pro-Abh complexes have been determined by X-ray crystallography at 2.0 A resolution (R-factor = 0.169 and 0.179, respectively), and analyzed in parallel with that of the thrombin:Dmc-azaLys acyl.enzyme adduct. Both Eoc-D-Phe-Pro-Abh and Cbz-Pro-Abh competitive inhibitors are accommodated in the thrombin active center, spanning the region between the aryl binding site and the S-1 primary specificity subsite. (C) 1997 Academic Press Limited.
引用
收藏
页码:558 / 569
页数:12
相关论文
共 49 条
[11]  
*CPP4, 1994, ACTA CRYSTALLOGR D, V50, P760
[12]   THE NA+ BINDING-SITE OF THROMBIN [J].
DICERA, E ;
GUINTO, ER ;
VINDIGNI, A ;
DANG, QD ;
AYALA, YM ;
WUYI, M ;
TULINSKY, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (38) :22089-22092
[13]   PROTEOLYTIC DERIVATIVES OF THROMBIN [J].
ELION, J ;
BOISSEL, JP ;
LEBONNIEC, B ;
BEZEAUD, A ;
JANDROTPERRUS, M ;
RABIET, MJ ;
GUILLIN, MC .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1986, 485 :16-26
[14]   ACCURATE BOND AND ANGLE PARAMETERS FOR X-RAY PROTEIN-STRUCTURE REFINEMENT [J].
ENGH, RA ;
HUBER, R .
ACTA CRYSTALLOGRAPHICA SECTION A, 1991, 47 :392-400
[15]  
FERRACCIOLI R, 1991, FARMACO, V46, P1517
[16]  
Fethiere J, 1996, PROTEIN SCI, V5, P1174
[17]  
FIEDLER F, 1981, METHOD ENZYMOL, V80, P493
[18]  
FRIEDRICH T, 1993, J BIOL CHEM, V268, P16216
[19]   An active-site titrant for chymotrypsin, and evidence that azapeptide esters are less susceptible to nucleophilic attack than ordinary esters [J].
Gassman, JM ;
Magrath, J .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (15) :1771-1774
[20]   CONVERSION OF THROMBIN INTO AN ANTICOAGULANT BY PROTEIN ENGINEERING [J].
GIBBS, CS ;
COUTRE, SE ;
TSIANG, M ;
LI, WX ;
JAIN, AK ;
DUNN, KE ;
LAW, VS ;
MAO, CT ;
MATSUMURA, SY ;
MEJZA, SJ ;
PABORSKY, LR ;
LEUNG, LLK .
NATURE, 1995, 378 (6555) :413-416